During this fireside chat, we welcome MannKind, ticker symbol of MNKD on the NASDAQ and their Chief Executive Officer, Mr. Michael Castagna. MannKind focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases.

This Fireside Chat was recorded during the Lytham Partners Winter 2021 Investor Conference.